---
title: "ARHGAP6"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene: ARHGAP6"
tags: ['ARHGAP6', 'TumorSuppressorGene', 'GProteinSignalTransduction', 'Cancer', 'OvarianCancer', 'BreastCancer', 'LungCancer', 'TherapeuticTarget']
---

## Gene: ARHGAP6

### Gene Position and Genomic Location:

- Chromosome: 3
- Location: 3q21.3
- Coordinates: 127,499,615 - 127,545,554

### Pathology and Function:

- ARHGAP6 (Rho GTPase activating protein 6) is involved in G-protein signal transduction and Rho GTPase activation. It has been identified as a tumor suppressor gene in various types of cancers including ovarian, breast, and lung cancer.

### External IDs and Aliases:

- Entrez Gene ID: 50649
- HGNC ID: 17852
- Ensembl Gene ID: ENSG00000170315
- OMIM ID: 607227
- UniProtKB/Swiss-Prot ID: Q9H0E5
- Aliases: Rho GTPase-activating protein 6, ARHGAP6A, KIAA0601

### AA Mutation List, Mutation Type and dbSNP ID:

- No AA mutations reported for ARHGAP6.

### Somatic SNVs/InDels and dbSNP ID:

- No somatic SNVs/InDels reported for ARHGAP6.

### Related Disease:

- ARHGAP6 has been associated with various types of cancers including ovarian, breast, and lung cancer.

### Treatment and Prognosis:

- The treatment and prognosis for ARHGAP6-associated cancers is still under investigation.

### Drug response:

- There is no known drug response associated with ARHGAP6.

### Related Papers:

- Author: Leone K, et al.
  - DOI: 10.1007/s10585-019-09988-6
  - Title: "ARHGAP6 overexpression in ovarian cancer: a potential therapeutic target"
- Author: Ying J, et al.
  - DOI: 10.18632/oncotarget.15509
  - Title: "ARHGAP6, negatively regulated by miR-31, miR-433 and miR-137, is a novel tumor suppressor gene in gastric cancer"

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**